Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain Journal Article


Authors: Inturrisi, C. E.; Colburn, W. A.; Kaiko, R. F.; Houde, R. W.; Foley, K. M.
Article Title: Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain
Abstract: Concentrations of methadone in plasma, estimates of pain relief, and pupillary size were determined after a single intravenous dose (10 to 30 mg) of methadone hydrochloride to eight patients with chronic pain, five of whom had cancer. The pharmacokinetic parameter estimates reveal rapid and extensive distribution (Varea) and a slow apparent elimination half-life (t1 2) (mean Varea = 3.59 L/kg and harmonic mean t1 2 = 23 hours). The harmonic mean blood clearance is 106 ml/min, the harmonic mean renal clearance is 3.9 ml/min, the mean hepatic extraction ratio is 0.089, and plasma protein binding is 86% to 89%. These results suggest that only the free (unbound) fraction of methadone present in blood is extracted by the liver and that methadone can be classified as a low (hepatic)-extraction drug. The data were fit to a pharmacokinetic-pharmacodynamic model to obtain estimates of the steady-state plasma methadone concentration required to produce 50% of the maximum pain relief. This value varied from 0.04 to 1.13 μg/ml (mean = 0.29 μg/ml). These results indicate substantial interindividual variation in the relationship between changes in plasma methadone concentration and analgesia in patients with chronic pain receiving opioids. A pharmacokinetic-pharmacodynamic model may be useful for the individualization of analgesic dosage and therefore the optimization of pain management in patients with chronic pain. © 1987.
Keywords: adult; aged; middle aged; major clinical study; blood proteins; pain; pharmacodynamics; cancer pain; central nervous system; chronic disease; pethidine; kinetics; blood pressure; chronic pain; methadone; morphine; drug therapy; hydromorphone; analgesia; therapy; half-life; intravenous drug administration; pharmacokinetics; levorphanol; oxycodone; visual system; cancer; humans; human; male; female; priority journal; pupil
Journal Title: Clinical Pharmacology & Therapeutics
Volume: 41
Issue: 4
ISSN: 0009-9236
Publisher: Nature Publishing Group  
Date Published: 1987-04-01
Start Page: 392
End Page: 401
Language: English
DOI: 10.1038/clpt.1987.47
PUBMED: 3829576
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 5 February 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kathleen M Foley
    199 Foley
  2. Raymond   Houde
    26 Houde